Table 1.

History of emergency use authorizations granted for vaccines in the USA [4, 8]

Date of first issuance	Treatment	Authorized use
14-Jan-05	Anthrax vaccine adsorbed	For prevention of inhalation of Anthrax by individuals at heightened risk of exposure due to attack with Anthrax
11-Dec-20	Pfizer-BioNTech COVID-19 vaccine	For the prevention of COVID-19 for individuals aged ≥ 16 years (Requested an EUA for the use in adolescents [53] and applied for full FDA approval [54]. Finally, on August 23, 2021, the FDA approved the vaccine for individuals 16 years or older [44].)
18-Dec-20	Moderna COVID-19 vaccine	For the prevention of COVID-19 for individuals aged ≥ 18 years
27-Feb-21	Janssen COVID-19 vaccine	For the prevention of Coronavirus Disease 2019 (COVID-19) for individuals aged ≥ 18 years

COVID-19 Coronavirus Disease 2019, EUA emergency use authorization, FDA US Food and Drug Administration